Candriam SCA’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Candriam SCA's VCYT Position: Q2 2026 in Review
Candriam SCA opened a new position in Veracyte (VCYT) in Q2 2026: 134,995 shares worth $7.92M. The stake represents 0.04% of the portfolio and ranks #313 among its holdings. This is a return to the name: Candriam SCA previously reported a position in VCYT as recently as Q3 2024.
Candriam SCA first reported a position in VCYT in Q1 2019 and has held it in 18 quarters since. The position peaked at $16.8M in Q4 2023. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Candriam SCA held 134,995 shares of Veracyte worth $7.92M as of Q2 2026.
- Veracyte was a new Candriam SCA position in Q2 2026.
- Veracyte made up 0.04% of Candriam SCA's portfolio in Q2 2026, its #313 holding.
- Candriam SCA first reported a position in Veracyte in Q1 2019 and has held it in 18 quarters since.
- Candriam SCA's Veracyte position peaked at $16.8M in Q4 2023.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.